Forty-eight rats were randomly distributed into three groups: HCA alone group, HCA combined with retrograde perfusion oxygenated compacted red blood cell group (HCArcp group), and sham operation group (sham op group); 16 rats in each group.
The Metastatic cell group clustered aside.
In addition, increasing numbers of α-SMA+ myoepithelial cells were found in the recurrent tumors from the combined treatment group, and these myoepithelial cells formed continuous layers around the tumor epithelial cells (Fig. 6l).
In order to further determine if endogenous cytotoxic CD8+ T-cells mediated the antitumor activity of the combined treatment group, we depleted CD8+ cells using anti-CD8 antherapytherapy in C57BL/6 mice implanted with SM1 tumors and receiving PLX3397 and PLX4032.
As shown in the CCK8 assay, the cell viability of the combined treatment group was significantly lower than that of the group transfected with non-sense control sequence (NC) and treated by MLN4924.
To prove the correlation between produced bioluminescence and therapeutic effect we performed nonparametric Spearman's correlation analysis within each group and then for the combined groups (two vectors combined, two cell lines combined, and overall) (Table 1).
Statistical analyses were conducted to assess differences in cell populations, 1) between the combined autistic group (HFA+LFA) and the control group, 2) between each of the autism subgroups and 3) among the three groups.
Compared to the mock control group, the combined oral nasal infection group exhibited higher frequencies of the CD4+ T-cell subset in the blood and the brain.
We then combined related cell types into larger groups but, again, no group-wise enrichment's were visible.
The depletion of CD8+ cells abrogated the antitumor activity of the combined treatment group.
The proportion of cells losing Δ ψm was significantly higher in combined treatment group than that in single drug groups.
